In conclusion, this study has shown that MYC overexpression is a poor predictor for bulky mass DLBCL patients, and its adverse prognostic effect is more pronounced in the high‐risk population and those with the GCB subtype. Here, MYC is linked to diffuse large B-cell lymphoma.